Found: 23
Select item for more details and to access through your institution.
Case Report: Development of Hodgkin's Disease in Patient Receiving Long-Term Administration of Dacarbazine and Interleukin-2 for Metastatic Melanoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 16, p. 1360
- By:
- Publication type:
- Article
Phase II Trial of High-Dose Intermittent Interleukin-2 in Metastatic Renal Cell Carcinoma: A Southwest Oncology Group Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 2, p. 143
- By:
- Publication type:
- Article
Immunotherapy of renal cell carcinoma.
- Published in:
- CA: A Cancer Journal for Clinicians, 1993, v. 43, n. 3, p. 177, doi. 10.3322/canjclin.43.3.177
- By:
- Publication type:
- Article
Colonic Small Cell Undifferentiated Carcinoma: A Distinct Pathological Diagnosis with Therapeutic Implications.
- Published in:
- American Journal of Gastroenterology (Springer Nature), 1987, v. 82, n. 4, p. 382
- By:
- Publication type:
- Article
Prospective evaluation of adrenal insufficiency in patients with adrenal metastasis.
- Published in:
- 1987
- By:
- Publication type:
- journal article
Meningeal carcinomatosis in head and neck cancer. Report of six cases and review of the literature.
- Published in:
- 1986
- By:
- Publication type:
- journal article
Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 323, doi. 10.1007/s10637-018-0692-8
- By:
- Publication type:
- Article
Concurrent whole brain radiotherapy and bortezomib for brain metastasis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Molecular Diagnostics of Melanoma Fine-Needle Aspirates.
- Published in:
- American Journal of Clinical Pathology, 2012, v. 138, n. 5, p. 670, doi. 10.1309/AJCPEQJW3PLOOZTC
- By:
- Publication type:
- Article
Inhibition of prostate cancer growth by estramustine and etoposide.
- Published in:
- Cancer (0008543X), 1995, v. 75, n. S7, p. 1920, doi. 10.1002/1097-0142(19950401)75:7+<1920::AID-CNCR2820751627>3.0.CO;2-Y
- By:
- Publication type:
- Article
Oral etoposide in the treatment of hormone-refractory prostate cancer.
- Published in:
- 1994
- By:
- Publication type:
- journal article
A phase II study of dacarbazine and cisplatin in combination with outpatient administered interleukin-2 in metastatic malignant melanoma.
- Published in:
- 1993
- By:
- Publication type:
- journal article
A phase I-II study of dacarbazine in combination with outpatient interleukin-2 in metastatic malignant melanoma.
- Published in:
- 1990
- By:
- Publication type:
- journal article
A phase 2, multicenter, open-label study of sepantronium bromide ( YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanoma.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 5, p. 643, doi. 10.1002/cam4.363
- By:
- Publication type:
- Article
Sunitinib in Patients With Metastatic Renal Cell Carcinoma.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 21, p. 2516, doi. 10.1001/jama.295.21.2516
- By:
- Publication type:
- Article
The Times They Are A-Changin' (Bob Dylan, 1964).
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Phase II trial of carboplatin and paclitaxel in cisplatin‐pretreated advanced transitional cell carcinoma: A Southwest Oncology Group studyAddress for reprints: Southwest Oncology Group (SWOG‐9457), Operations Office, 14980 Omicron Dr., San Antonio, TX 78245‐3217; Fax: (210) 677‐0006; E‐mail: pubs@swog.org
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 8, p. 1627
- By:
- Publication type:
- Article
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 98, n. 8, p. 1603, doi. 10.1002/cncr.11686
- By:
- Publication type:
- Article
Prevalence of drug-drug interactions in oncology patients enrolled on National Clinical Trials Network oncology clinical trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 3, p. 432, doi. 10.1002/cncr.29055
- By:
- Publication type:
- Article
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 trial of complete resection for stage IV melanoma.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 20, p. 4740, doi. 10.1002/cncr.26111
- By:
- Publication type:
- Article
The impact of BRAF mutation status on clinical outcomes with anti‐PD‐1 monotherapy versus combination ipilimumab/nivolumab in treatment‐naïve advanced stage melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2021, v. 34, n. 3, p. 629, doi. 10.1111/pcmr.12944
- By:
- Publication type:
- Article